CYPRENORPHINE

- Everything we could find out about it

Home ] [ Controlled Substances ] [ Opioids ]

Created May 2019 | Updated Oct 2020

CYPRENORPHINE

  • [M285]

DEA CODE 9054: Schedule 1 Narcotic

Cyprenorphine (the hallucinogenic opioid)
Cyprenorphine (M-285) is a drug which is an opioid derivative. It is related to more well-known opioids such as buprenorphine, which is used as an analgesic and for the treatment of opioid addiction, and diprenorphine, which is used as an antidote to reverse the effects of other opioids.

Cyprenorphine has mixed agonist-antagonist effects at opioid receptors, like those of buprenorphine. However the effects of cyprenorphine are somewhat different, as it produces pronounced dysphoric and hallucinogenic effects which limit its potential use as an analgesic.

Cyprenorphine is a mixed agonist-antagonist of opioid receptors. In clinical trials, administration of cyprenorphine induced psychotomimetic effects in pre-operative patients.

An opioid drug. It is related to more well-known opioids such as buprenorphine, which is used as an analgesic and for the treatment of opioid addiction. However the effects of cyprenorphine are somewhat different, as it produces pronounced dysphoric and hallucinogenic effects which limit its potential use as an analgesic.

  
Some Effects of a Hallucinogenic Compound (Cyprenorphine Hydrochloride; M 285) on the Light Reinforced Behaviour of Rats | Nature - CYPRENORPHINE hydrochloride (M 285)1 is a morphine antagonist with greater potency (about 35 times) parenterally and longer duration of action than nalorphine. It has been surveyed for ...
Thursday December 19, 2024 - nature.com

  
Opioids | Link to this page

Home ] [ Controlled Substances ] [ Sources ]


· Controlled Substances
· Opioids
· Cyprenorphine